E-DRUG Archives (by thread)

Date Index

[e-drug] Spamming and viruses, E-drug

[e-drug] Patents in Africa: PhRMA's August 1, 2001 Survey, James Love

[e-drug] Australian Prescriber October 2001, Susan Reid

[e-drug] Sleeping sickness prevention, E-drug

[e-drug] Table of Contents Essential Drugs Monitor 28&29 - 2000, EDM Documentation Centre

[e-drug] Essential Drugs Monitor subscribing information, EDM Documentation Centre

[e-drug] Essential Drugs Monitor (cont'd), Thomas Schwarz

[e-drug] Newsweek and Direct to Consumer Advertising, RxUpdate

[e-drug] Fraud by Abbott and Takeda in Medicare and Medicaid, E-drug

[e-drug] HIV patients in Sub-Saharan countries with ARV patents, James Love

[e-drug] FDA warns Merck, E-drug

[e-drug] Effective treatments for mental illness, E-drug

[e-drug] Subscribing to EDM, Hilbrand Haak

[e-drug] Fraud by Abbott and Takeda (cont'd), Tim Dodd

<Possible follow-ups>
[e-drug] Fraud by Abbott and Takeda (cont'd), John Urquhart
[e-drug] Fraud by Abbott and Takeda (cont'd), E-drug

[e-drug] Vaccines and vaccination, Valeria Frighi

[e-drug] New report: Accessing ARVs, Carmen Perez

[e-drug] DTCA for prescription drugs, E-drug

[e-drug] Canadian strategy to reduce medical error, E-drug

[e-drug] Sub-Saharan ARV patents by population and income, James Love

[e-drug] US scientist named as possible head of US FDA, E-drug

[e-drug] Media advocates support access to treatment campaign, Omololu Falobi

[e-drug] Short course in community-based health promotion, John Hubley

[e-drug] GSK licenses ARVs to South African generic manufacturer, andy

[e-drug] Annan Discusses AIDS Drug Discounts with Drug Companies, e-drug

[e-drug] GSK/BI and CIPLA prices for South Africa, Ip-health

[e-drug] Time needed to provide bioequivalence studies, James Love

[e-drug] Conference pharmacists and AIDS developing countries, Carinne Bruneton

[e-drug] National Medicines Symposium 2002, Libby Roughead

[e-drug] Upcoming course on research methodology, Jette Norgaard

[e-drug] Fatal Imbalance: MSF on R&D for neglected diseas, Mai Do

[e-drug] Time needed to provide bioequivalence studies (cont'd), Esthi Beukes

<Possible follow-ups>
[e-drug] Time needed to provide bioequivalence studies (cont'd), James Love
[e-drug] Time needed to provide bioequivalence studies (cont'd), James Love
[e-drug] Time needed to provide bioequivalence studies (cont'd), Esthi Beukes

[e-drug] Act Up-Paris on EU's paper at the TRIPS council, Gaelle Krikorian

[e-drug] European Parliament on poverty and access to medicines, E-drug

[e-drug] Petition from Oxfam about WTO patent rules, Els Witschge

[e-drug] WHO Dictionary, Sana Sukkari

[e-drug] Looking for 'Roche versus Adams', Siobhan Morrissey

[e-drug] WHO Dictionary (cont'd), Mary Couper

[e-drug] Intellectual property rights and medicines debates, e-drug

[e-drug] Street Price: new VSO report on access to meds, Ken . Bluestone . ken . bluestone

[e-drug] Conference pharmacists and AIDS (cont'd), Mary Ojoo

[e-drug] Short course in sexual and reproductive health research, Sarah Castle

[e-drug] New GDF websites, Karen Cicerik

[e-drug] Assistance requested, Dominic Szewczyk

[e-drug] New website, Jatinder Singh

[e-drug] NYTimes on Cipro, Cipla, and Bayer, Asia Russell

[e-drug] Kofi Annan & 7 drug companies on ARV access, e-drug

[e-drug] Attaran/Gillespie-White and PhRMA patent surveys, James . Love , INTERNET : love

[e-drug] Attaran/Gillespie-White and PhRMA patent surveys (cont'd), Dean Baker

<Possible follow-ups>
[e-drug] Attaran/Gillespie-White and PhRMA patent surveys (cont'd), E-drug
[e-drug] Attaran/Gillespie-White and PhRMA patent surveys (cont'd), Richard Laing
[e-drug] Attaran/Gillespie-White and PhRMA patent surveys (cont'd), Jerome Dumoulin
[e-drug] Attaran/Gillespie-White and PhRMA patent surveys (cont'd), Mauro Guarinieri
[e-drug] Attaran/Gillespie-White and PhRMA patent surveys (cont'd), James Russo
[e-drug] Attaran/Gillespie-White and PhRMA patent surveys (cont'd), Colleen Fuller
[e-drug] Attaran/Gillespie-White and PhRMA patent surveys (cont'd), Leo Offerhaus

[e-drug] Attaran/Gillespie-White and PhRMA patent survey (cont'd), Julia Double

[e-drug] WHO Fact Sheet on Anthrax, pazvakavambwab

[e-drug] Drugs for Afganistan, educacion

[e-drug] Trizivir patents in Africa, Mike Palmedo

[e-drug] Drugs for Afganistan (cont'd), George Havens

<Possible follow-ups>
[e-drug] Drugs for Afganistan (cont'd), James Russo

[e-drug] Health research divide, E-drug

[e-drug] Canada overrides patent for cipro to treat anthrax, Ellen 't Hoen

[e-drug] WB/IMF/US shenanigans, E-drug

[e-drug] Selected Ciprofloxacin prices, James Love

[e-drug] Selected Ciprofloxacin prices (cont'd), Leo Offerhaus

<Possible follow-ups>
[e-drug] Selected Ciprofloxacin prices (cont'd), James Love

[e-drug] Patents and Access to drugs, Murtada Sesay

[e-drug] Patents and Access to drugs (cont'd), Cecile De Sweemer

<Possible follow-ups>
[e-drug] Patents and Access to drugs (cont'd), Colleen Fuller

[e-drug] Literature review on anthrax prevention and treatment, Leo Offerhaus

[e-drug] Consumption & quantification of drugs in Nepal, Dept of Drug Administration

[e-drug] % Generics vs branded products, Douglas Defty

[e-drug] MSF Pharmacists, Isabelle Saussereau

[e-drug] French drug firm pleads guilty - pays US$33 Million, E-drug

[e-drug] Literature review on anthrax (cont'd), Steve Toovey

<Possible follow-ups>
[e-drug] Literature review on anthrax (cont'd), Kirsten Myhr
[e-drug] Literature review on anthrax (cont'd), Leo Offerhaus
[e-drug] Literature review on anthrax (cont'd), James Love
[e-drug] Literature review on anthrax (cont'd), John Urquhart

[e-drug] Financial Times on patent abuse, E-drug

[e-drug] Course Pharmacoeconomics - Evidence, Money & Selection, David Henry

[e-drug] % Generics vs branded products (cont'd), Joel Lexchin

<Possible follow-ups>
[e-drug] % Generics vs branded products (cont'd), Kirsten Myhr

[e-drug] South Asia conference on Drug Quality postponed, Nancy Blum

[e-drug] Medicilisation - A way of life, BUKO Pharma-Kampagne

[e-drug] Cipro and emergency, Ellen 't Hoen

[e-drug] Medicilisation - A way of life (cont'd), Niyada Kiatying-Angsulee

<Possible follow-ups>
[e-drug] Medicilisation - A way of life (cont'd), Carlo Struglia
[e-drug] Medicilisation - A way of life (cont'd), Steve Toovey
[e-drug] Medicilisation - A way of life (cont'd), Basim Saab

[e-drug] Call for Abstracts - South Asia Pharmaceuticals Conference, Nancy Blum

[e-drug] French drug firm pleads guilty (cont'd), Leo Offerhaus

[e-drug] class action on Bayer's ciprofloxacin price, CBGnetwork

[e-drug] International Conference on Harmonization, Wong Wai See

<Possible follow-ups>
[e-drug] International Conference on Harmonization, Wilbert . Bannenberg . wbannenberg

[e-drug] International Conference on Harmonization (cont'd), BUKO Pharma-Kampagne

<Possible follow-ups>
[e-drug] International Conference on Harmonization (cont'd), E-drug

[e-drug] Medicalisation - Hepatitis B vaccine safety (cont'd), Klara Tisocki

[e-drug] Post-exposure prophylaxis for anthrax, Peter Lurie

[e-drug] Medicalisation - A way of life (cont'd), K Arnold Chan

[e-drug] Injection practices - Uganda study, Kirsten Myhr

[e-drug] Post-exposure prophylaxis for anthrax (cont'd), Dr.L.Offerhaus

<Possible follow-ups>
[e-drug] Post-exposure prophylaxis for anthrax (cont'd), John Urquhart

[e-drug] WSJ on USG/Bayer deal, E-drug

[e-drug] Guardian on Losec patent, E-drug

[e-drug] Protecting Pharma Companies from threat of Bio-Terrorism, Mark Weisbrot

[e-drug] Comparative drug prices, Albert Figueras

[e-drug] WTO: Lamy must oppose the US goverment strategy, Olivier Jablonski

[e-drug] LSHTM/GMP fellow/studentships, E-drug

[e-drug] Contents of the Remed Journal, nr 25, Carinne Bruneton

[e-drug] Dow Jones: WTO and US threat to Bayer patent, E-drug

[e-drug] Doxycycline becomes D.C.'s anthrax drug of choice, E-drug

[e-drug] WSJ on side effects of Fluoroquinolones, E-drug

[e-drug] Doxycycline becomes D.C.'s anthrax drug (cont'd), Leo Offerhaus

<Possible follow-ups>
[e-drug] Doxycycline becomes D.C.'s anthrax drug (cont'd), James Love
[e-drug] Doxycycline becomes D.C.'s anthrax drug (cont'd), Leo Offerhaus
[e-drug] Doxycycline becomes D.C.'s anthrax drug (cont'd), James Love
[e-drug] Doxycycline becomes D.C.'s anthrax drug (cont'd), Kirsten Myhr
[e-drug] Doxycycline becomes D.C.'s anthrax drug (cont'd), James Love

[e-drug] Substandard drugs, E-drug

[e-drug] Anti-hypertensive drug prices, Douglas Ball

[e-drug] Comparative drug prices (con'd), Bonnie Fundafunda

[e-drug] Japan drug formulary, Elena Romano

[e-drug] Olivieri; need for better patient protection in drug trials, Barbara Mintzes

[e-drug] Health and 'commodities', Fawzia Rasheed

[e-drug] Rich countries block life-saving drug deal for poor countries, Mohga Kamal Smith

[e-drug] Rich countries block life-saving drug deal (cont'd), Anni Long

[e-drug] Health and 'commodities' (cont'd), Rich Mahoney

[e-drug] Japan drug formulary (cont'd), Hank Malinowski

[e-drug] USA Today: Cipro and how drugmakers protect profits, E-drug

[e-drug] MSF DOHA Briefing Document, Ellen 't Hoen

[e-drug] NYTimes: The Urgency of Cheaper Drugs, E-drug

[e-drug] Patents, Commodities..., Bonnie Fundafunda

Mail converted by MHonArc 2.6.8